SECOND SIGHT MED PRODS INC - COM (EYES)

CUSIP: 81362J100

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
1,772,864
Share change
+494,877
Total reported value
$24,130,668
Put/Call ratio
536%
Price per share
$13.61
Number of holders
49
Value change
+$6,762,232
Number of buys
30
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 81362J100?
CUSIP 81362J100 identifies EYES - SECOND SIGHT MED PRODS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM (EYES) as of Q2 2015

As of 30 Jun 2015, SECOND SIGHT MED PRODS INC - COM (EYES) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,772,864 shares. The largest 10 holders included BlackRock Fund Advisors, ORACLE INVESTMENT MANAGEMENT INC, BlackRock Institutional Trust Company, N.A., SUSQUEHANNA INTERNATIONAL GROUP, LLP, TIAA CREF INVESTMENT MANAGEMENT LLC, BOLTON LP, STATE STREET CORP, VANGUARD GROUP INC, Granite Investment Partners, LLC, and Harvest Capital Strategies LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.